The trajectory of companies tied to Sildenafil's legacy presents a complex investment picture . While the initial success generated substantial returns , generic alternatives have significantly diminished https://icelisting.com/story22921114/copyright-s-flagship-product-and-big-pharma-a-speculative-investment